Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Levente Kürti"'
Autor:
Balázs Szalontai, Levente Kürti, Orsolya Jójárt-Laczkovich, Piroska Szabó-Révész, Mária A. Deli, Gabriella Farkas, Erik Glässer, Csaba Mártha
Publikováno v:
European Polymer Journal. 49:2426-2432
Particle size reduction to the submicron region in a grinding process demands a high energy input. This grinding energy requirement can be reduced by means of a suitable additive, e.g. polymer, and performing a co-grinding process. Although these exc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f118f56a64c8ed8070bd6fd1bbdb08b
https://doi.org/10.1016/j.eurpolymj.2013.03.006
https://doi.org/10.1016/j.eurpolymj.2013.03.006
Autor:
Mónika Vastag, Alexandra Bocsik, Piroska Szabó-Révész, Mária A. Deli, Csilla Bartos, Emese Kápolna, Rita Ambrus, Levente Kürti, Árpád Márki, Szilvia Veszelka, Róbert Gáspár
Publikováno v:
European Journal of Pharmaceutical Sciences. 50:86-92
The nasal pathway represents a non-invasive route for delivery of drugs to the systemic circulation. Nanonization of poorly soluble drugs offers a possibility to increase dissolution properties, epithelial permeability or even bioavailability. The ai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18ca2ef1ac48e8d80389fa82f2b9db8c
https://doi.org/10.1016/j.ejps.2013.03.012
https://doi.org/10.1016/j.ejps.2013.03.012
Autor:
László G. Puskás, Szilvia Veszelka, Levente Kürti, Béla Ózsvári, Alexandra Bocsik, Ágnes Kittel, Piroska Szabó-Révész, Mária A. Deli
Publikováno v:
Cytotechnology. 65:395-406
The nasal pathway represents an alternative route for non-invasive systemic administration of drugs. The main advantages of nasal drug delivery are the rapid onset of action, the avoidance of the first-pass metabolism in the liver and the easy applic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38a6371b0aeeb7ce4790135a6c125257
https://doi.org/10.1007/s10616-012-9493-7
https://doi.org/10.1007/s10616-012-9493-7
Autor:
László G. Puskás, Levente Kürti, Szilvia Veszelka, Ngo Thi Khue Dung, Ágnes Kittel, Piroska Szabó-Révész, Mária A. Deli, Alexandra Bocsik, Béla Ózsvári
Publikováno v:
Toxicology in Vitro. 26:445-454
Sucrose esters are effective solubilizers and there is an interest to use them as pharmaceutical excipients for nasal drug delivery. We have determined for the first time the non-toxic doses of laurate and myristate sucrose esters by four independent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe0b99dd63729be0cef8a14549f80db6
https://doi.org/10.1016/j.tiv.2012.01.015
https://doi.org/10.1016/j.tiv.2012.01.015
Publikováno v:
Powder Technology. 212:210-217
Co-grinding is a procedure for the preparation of nanoparticles in which the drug is ground together with one or more excipients. The grinding of meloxicam, a crystalline solid, together with amorphous polyvinylpyrrolidone (PVP) or semi-crystalline p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fef26ab5f3e23c7e25a1d96d38d293d3
https://doi.org/10.1016/j.powtec.2011.05.018
https://doi.org/10.1016/j.powtec.2011.05.018
Autor:
Zsuzsa Penke, A. Fehér, I. Erős, János Horváth, Lívia Fülöp, Botond Penke, Szilvia Veszelka, Ágnes Kasza, Anita Kurunczi, Piroska Szabó-Révész, Mária A. Deli, Levente Kürti, Sándor Horvát, Gábor Balogh, Eszter Sipos, Árpád Párducz
Publikováno v:
Cellular and Molecular Neurobiology. 30:405-413
(1) Intranasal administration is a non-invasive and effective way for the delivery of drugs to brain that circumvents the blood-brain barrier. The aims of the study were to test a nasal delivery system for human beta-amyloid (A beta) peptides, to mea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6833138c305e4e46fe32e796ee1ae60
https://doi.org/10.1007/s10571-009-9463-6
https://doi.org/10.1007/s10571-009-9463-6
Publikováno v:
Scientia Pharmaceutica. 78:579-579
Studies on nasal epithelial models are important to develop vehicles for systemic nasal drug delivery, and also for targeting drugs to brain via the nasal route. [...]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59b5238ff914ed8de95a1796cd73fdad
https://doi.org/10.3797/scipharm.cespt.8.lnt05
https://doi.org/10.3797/scipharm.cespt.8.lnt05
Autor:
Szilvia Veszelka, A. Fehér, S. Horvát, Levente Kürti, I. Erős, Piroska Révész, Mária A. Deli, A. Kurunczi
Publikováno v:
European Journal of Pharmaceutical Sciences. 32:S13
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::575ce6c742a54e188bf3cfce6057433f
https://doi.org/10.1016/j.ejps.2007.05.027
https://doi.org/10.1016/j.ejps.2007.05.027
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.